Immune Checkpoint Inhibitor-Induced Central Diabetes Insipidus: Looking for the Needle in the Haystack or a Very Rare Side-Effect to Promptly Diagnose?

Immune checkpoint inhibitors have improved the survival in patients affected by an increasing number of malignancies, but they may also trigger various autoimmune side-effects, including endocrinopathies. Very rarely, immune checkpoint inhibitors have been reported to cause central diabetes insipidu...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Agnese Barnabei, Lidia Strigari, Andrea Corsello, Rosa Maria Paragliola, Luca Falzone, Roberto Salvatori, Salvatore Maria Corsello, Francesco Torino
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-03-01
coleção:	Frontiers in Oncology
Assuntos:	immune checkpoint inhibitors diabetes insipidus hypophysitis endocrinopathy posterior pituitary
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2022.798517/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!